Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes

BMC Nephrol. 2020 May 28;21(1):200. doi: 10.1186/s12882-020-01854-1.

¹ Kaiser Permanente Center for Health Research, 3800 N. Interstate Avenue, Portland, Oregon, USA. greg.nichols@kpchr.org.
² Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
³ Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.
⁴ Kaiser Permanente Center for Health Research, 3800 N. Interstate Avenue, Portland, Oregon, USA.
⁵ Vth Department of Medicine, University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany.

Abstract

An amendment to this paper has been published and can be accessed via the original article.